Answers are grounded in this paper and cite their sources.
Immunocompromised individuals are susceptible to pulmonary aspergillus infection, but invasive aspergillus infection is rarely seen in the presence of normal immunity. Some reports have described invasive pulmonary aspergillosis (IPA) occurring in chronic obstructive pulmonary disease (COPD) patients receiving corticosteroid treatment. We report a 74-yearold male patient with COPD who was treated regularly with inhaled corticosteroids. He presented with fever, productive cough and exacerbation of dyspnea accompanied with chest radiographic abnormalities on admission. IPA was diagnosed soon thereafter by bronchoscopy with bronchial biopsy and bronchoalveolar lavage (BAL). A new antifungal agent (caspofungin) was used which successfully treated the disease within 14 days. In summary, since patients with underlying COPD and corticosteroids use are predisposed to IPA, physicians should consider such an infection, and bronchoscopy may be helpful in the early diagnosis. Echinocandins, such as caspofungin, are effective in the treatment of IPA.
No takes yet. Share an insight, caveat, or question.
Chang et al. (2009) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: